AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29

Authors: Takeda, K Hayakawa, Y Smyth, M Kayagaki, N Yamaguchi, N Kakuta, S Iwakura, Y Yagita, H Okumura, K
Citation: K. Takeda et al., Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells, NAT MED, 7(1), 2001, pp. 94-100

Authors: Oshima, K Yanase, N Ibukiyama, C Yamashina, A Kayagaki, N Yagita, H Mizuguchi, J
Citation: K. Oshima et al., Involvement of trail/trail-R interaction in IFN-alpha-induced apoptosis ofdaudi B lymphoma cells, CYTOKINE, 14(4), 2001, pp. 193-201

Authors: Nisihara, T Ushio, Y Higuchi, H Kayagaki, N Yamaguchi, N Soejima, K Matsuo, S Maeda, H Eda, Y Okumura, K Yagita, H
Citation: T. Nisihara et al., Humanization and epitope mapping of neutralizing anti-human fas ligand monoclonal antibodies: Structural insights into Fas/Fas ligand interaction, J IMMUNOL, 167(6), 2001, pp. 3266-3275

Authors: Smyth, MJ Cretney, E Takeda, K Wiltrout, RH Sedger, LM Kayagaki, N Yagita, H Okumura, K
Citation: Mj. Smyth et al., Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis, J EXP MED, 193(6), 2001, pp. 661-670

Authors: Miura, Y Misawa, N Maeda, N Inagaki, Y Tanaka, Y Ito, M Kayagaki, N Yamamoto, N Yagita, H Mizusawa, H Koyanagi, Y
Citation: Y. Miura et al., Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4(+) T cells in HIV-1-infected hu-PBL-NOD-SCID mice, J EXP MED, 193(5), 2001, pp. 651-659

Authors: Sato, K Hida, S Takayanagi, H Yokochi, T Kayagaki, N Takeda, K Yagita, H Okumura, K Tanaka, N Taniguchi, T Ogasawara, K
Citation: K. Sato et al., Antiviral response by natural killer cells through TRAIL gene induction byIFN-alpha/beta, EUR J IMMUN, 31(11), 2001, pp. 3138-3146

Authors: Nieda, M Nicol, A Koezuka, Y Kikuchi, A Lapteva, N Tanaka, Y Tokunaga, K Suzuki, K Kayagaki, N Yagita, H Hirai, H Juji, T
Citation: M. Nieda et al., TRAIL expression by activated human CD4(+)V alpha 24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukema cells, BLOOD, 97(7), 2001, pp. 2067-2074

Authors: Shinohara, H Kayagaki, N Yagita, H Oyaizu, N Ohba, M Kuroki, T Ikawa, Y
Citation: H. Shinohara et al., A protective role of PKC epsilon against TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in glioma cells, BIOC BIOP R, 284(5), 2001, pp. 1162-1167

Authors: Seino, K Setoguchi, Y Ogino, T Kayagaki, N Akiba, H Nakano, H Taniguchi, H Takada, Y Yuzawa, K Todoroki, T Fukuchi, Y Yagita, H Okumura, K Fukao, K
Citation: K. Seino et al., Protection against Fas-mediated and tumor necrosis factor receptor 1-mediated liver injury by blockade of FADD without loss of nuclear factor-kappa Bactivation, ANN SURG, 234(5), 2001, pp. 681-688

Authors: Kawamura, T Azuma, M Kayagaki, N Shimada, S Yagita, H Okumura, K
Citation: T. Kawamura et al., Fas/Fas ligand-mediated apoptosis of murine Langerhans cells, J DERMA SCI, 22(2), 2000, pp. 96-101

Authors: Nakajima, A Hirai, H Kayagaki, N Yoshino, S Hirose, S Yagita, H Okumura, K
Citation: A. Nakajima et al., Treatment of lupus in NZB/W F1 mice with monoclonal antibody against Fas ligand, J AUTOIMMUN, 14(2), 2000, pp. 151-157

Authors: Saitoh, A Kawanabe, T He, WD Kayagaki, N Kawamura, T Yagita, H Okumura, K Shimada, S
Citation: A. Saitoh et al., Selective upregulation of fibroblast fas ligand expression, and prolongation of Fas/Fas ligand-mediated skin allograft survival, by retinoic acid: The skin as a retinoide-inducible immune privilege site, J INVES DER, 115(2), 2000, pp. 154-161

Authors: Yamanaka, K Tanaka, M Tsutsui, H Kupper, TS Asahi, K Okamura, H Nakanishi, K Suzuki, M Kayagaki, N Black, RA Miller, DK Nakashima, K Shimizu, M Mizutani, H
Citation: K. Yamanaka et al., Skin-specific caspase-1-transgenic mice show cutaneous apoptosis and pre-endotoxin shock condition with a high serum level of IL-18, J IMMUNOL, 165(2), 2000, pp. 997-1003

Authors: Kim, S Kim, KA Hwang, DY Lee, TH Kayagaki, N Yagita, H Lee, MS
Citation: S. Kim et al., Inhibition of autoimmune diabetes by Fas ligand: The paradox is solved, J IMMUNOL, 164(6), 2000, pp. 2931-2936

Authors: Nakayama, M Kayagaki, N Yamaguchi, N Okumura, K Yagita, H
Citation: M. Nakayama et al., Involvement of TWEAK in interferon gamma-stimulated monocyte cytotoxicity, J EXP MED, 192(9), 2000, pp. 1373-1379

Authors: Tsutsui, H Kayagaki, N Kuida, K Nakano, H Hayashi, N Takeda, K Matsui, K Kashiwamura, S Hada, T Akira, S Yagita, H Okamura, H Nakanishi, K
Citation: H. Tsutsui et al., Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice, IMMUNITY, 11(3), 1999, pp. 359-367

Authors: Nagao, M Nakajima, Y Hisanaga, M Kayagaki, N Kanehiro, H Aomatsu, Y Ko, S Yagita, H Yamada, T Okumura, K Nakano, H
Citation: M. Nagao et al., The alteration of Fas receptor and ligand system in hepatocellular carcinomas: How do hepatoma cells escape from the host immune surveillance in vivo?, HEPATOLOGY, 30(2), 1999, pp. 413-421

Authors: Hattori, K Hirano, T Ushiyama, C Miyajima, H Yamakawa, N Ikeda, S Yoshino, K Tateno, M Oshimi, K Kayagaki, N Yagita, H Okumura, K
Citation: K. Hattori et al., A metalloproteinase inhibitor prevents acute graft-versus-host disease in mice after bone marrow transplantation, BONE MAR TR, 23(12), 1999, pp. 1283-1289

Authors: Seino, K Kayagaki, N Yamaguchi, N Takada, Y Uyama, S Kiuchi, T Tanaka, K Yagita, H Okumura, K Fukao, K
Citation: K. Seino et al., Soluble forms of CD95 and CD95 ligand after living related liver transplantation, TRANSPLANT, 67(4), 1999, pp. 634-636

Authors: Kayagaki, N Yamaguchi, N Nakayama, M Takeda, K Akiba, H Tsutsui, H Okamura, H Nakanishi, K Okumura, K Yagita, H
Citation: N. Kayagaki et al., Expression and function of TNF-related apoptosis-inducing ligand on murineactivated NK cells, J IMMUNOL, 163(4), 1999, pp. 1906-1913

Authors: Kayagaki, N Yamaguchi, N Nakayama, M Kawasaki, A Akiba, H Okumura, K Yagita, H
Citation: N. Kayagaki et al., Involvement of TNF-related apoptosis-inducing ligand in human CD4(+) T cell-mediated cytotoxicity, J IMMUNOL, 162(5), 1999, pp. 2639-2647

Authors: Hyodo, Y Matsui, K Hayashi, N Tsutsui, H Kashiwamura, S Yamauchi, H Hiroishi, K Takeda, K Tagawa, Y Iwakura, Y Kayagaki, N Kurimoto, M Okamura, H Hada, T Yagita, H Akira, S Nakanishi, K Higashino, K
Citation: Y. Hyodo et al., IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor, J IMMUNOL, 162(3), 1999, pp. 1662-1668

Authors: Kayagaki, N Yamaguchi, N Nakayama, M Eto, H Okumura, K Yagita, H
Citation: N. Kayagaki et al., Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism forthe antitumor effects of type IIFNs, J EXP MED, 189(9), 1999, pp. 1451-1460

Authors: Hiromatsu, Y Hoshino, T Yagita, H Koga, M Sakisaka, S Honda, J Yang, D Kayagaki, N Okumura, K Nonaka, K
Citation: Y. Hiromatsu et al., Functional Fas ligand expression in thyrocytes from patients with Graves' disease, J CLIN END, 84(8), 1999, pp. 2896-2902

Authors: Kim, YH Kim, SS Kim, KA Yagita, H Kayagaki, N Kim, KW Lee, MS
Citation: Yh. Kim et al., Apoptosis of pancreatic beta-cells detected in accelerated diabetes of NODmice: no role of Fas-Fas ligand interaction in autoimmune diabetes, EUR J IMMUN, 29(2), 1999, pp. 455-465
Risultati: 1-25 | 26-29